Strengthening Competitiveness through New Product Development and R&D Investment
First written in FY2016. 23 of 30 entries say "Restated". Latest entry: FY2026.
115 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The breakdown of research and development investment for the consolidated fiscal year, including development costs capitalised as intangible assets, was as follows: Communications Measurement, ¥7,740 million; PQA, ¥1,372 million; Environmental Measurement, ¥766 million; Other, ¥139 million; and basic research and development, ¥160 million, for a total of ¥10,179 million, or 8.7% of revenue.」
The company disclosed full-year research and development investment of ¥10,179 million, or 8.7% of revenue, and advanced product development in Communications Measurement, PQA and Environmental Measurement, including high-speed optical communications, NTN and 6G, pharmaceutical quality inspection and EV evaluation. - FY2026-H1RestatedAnnual report
「Research and development investment during the current interim consolidated accounting period, including development costs capitalised as intangible assets, amounted to ¥4,653 million. There were no material changes in the status of the Group's research and development activities during the current interim consolidated accounting period.」
The company continued its research and development investment and disclosed investment of ¥4,653 million for the current interim consolidated accounting period. It stated that there were no material changes in the status of its research and development activities. - FY2025AdvancedAnnual report
「The breakdown of research and development investment for the consolidated fiscal year, including development costs capitalised as intangible assets, was as follows: Communications Measurement, ¥7,276 million; PQA, ¥1,663 million; Environmental Measurement, ¥512 million; Other businesses, ¥142 million; and basic research and development, ¥284 million, for a total of ¥9,879 million, or 8.7% of revenue.」
The company reported full-year research and development investment of ¥9,879 million and continued developing new products and solutions in Communications Measurement, PQA and Environmental Measurement. - FY2025-H1RestatedAnnual report
「Research and development investment during the current interim consolidated accounting period, including development costs capitalised as intangible assets, amounted to ¥5,152 million. There were no material changes in the status of the Group's research and development activities during the current interim consolidated accounting period.」
The company continued its research and development investment and disclosed investment of ¥5,152 million for the current interim consolidated accounting period. It stated that there were no material changes in the status of its research and development activities. - FY2024-Q3RestatedAnnual report
「Research and development investment during the current third-quarter consolidated cumulative period, including development costs capitalised as intangible assets, amounted to ¥7,440 million. There were no material changes in the status of the Group's research and development activities during the current third-quarter consolidated cumulative period.」
The company continued its research and development investment and disclosed investment of ¥7,440 million for the current third-quarter cumulative period. It stated that there were no material changes in the status of its research and development activities. - FY2024-Q2RestatedAnnual report
「Research and development investment during the current second-quarter consolidated cumulative period, including development costs capitalised as intangible assets, amounted to ¥4,967 million. There were no material changes in the status of the Group's research and development activities during the current second-quarter consolidated cumulative period.」
The company recognised research and development investment of ¥4,967 million and stated that there were no material changes in the status of its research and development activities. - FY2024-Q1RestatedAnnual report
「Research and development investment during the current first-quarter consolidated cumulative period, including development costs capitalised as intangible assets, amounted to ¥2,511 million. There were no material changes in the status of the Group's research and development activities during the current first-quarter consolidated cumulative period.」
The company recognised research and development investment of ¥2,511 million and stated that there were no material changes in the status of its research and development activities. - FY2023AdvancedAnnual report
「The breakdown of research and development investment for the consolidated fiscal year, including development costs capitalised as intangible assets, was as follows: Communications Measurement, ¥8,785 million; PQA, ¥1,760 million; Other businesses, ¥689 million; and basic research and development, ¥184 million, for a total of ¥11,420 million, or 10.3% of revenue.」
The company disclosed full-year research and development investment of ¥11,420 million, or 10.3% of revenue, and advanced the development of specific products and solutions including 5G, O-RAN, Wi-Fi 7, PCI Express 6.0 and Local5G. - FY2023-Q3RestatedAnnual report
「Research and development investment during the current third-quarter consolidated cumulative period, including development costs capitalised as intangible assets, amounted to ¥8,813 million. There were no material changes in the status of the Group's research and development activities during the current third-quarter consolidated cumulative period.」
The company continued its research and development investment and disclosed investment of ¥8,813 million for the current third-quarter cumulative period. It stated that there were no material changes in the status of its research and development activities. - FY2023-Q2RestatedAnnual report
「Research and development investment during the current second-quarter consolidated cumulative period, including development costs capitalised as intangible assets, amounted to ¥6,017 million. There were no material changes in the status of the Group's research and development activities during the current second-quarter consolidated cumulative period.」
The company continued its research and development investment and disclosed investment of ¥6,017 million for the current second-quarter cumulative period. It stated that there were no material changes in the status of its research and development activities. - FY2022AdvancedAnnual report
「The breakdown of research and development investment for the consolidated fiscal year, including development costs capitalised as intangible assets, was as follows: Communications Measurement, ¥8,964 million; PQA, ¥1,758 million; Other businesses, ¥572 million; and basic research and development, ¥91 million, for a total of ¥11,386 million, or 10.8% of revenue.」
The company disclosed research and development investment of ¥11,386 million for fiscal 2021, or 10.8% of revenue, and continued investment including Communications Measurement, PQA and basic research. - FY2022-Q3RestatedAnnual report
「Research and development investment during the current third-quarter consolidated cumulative period, including development costs capitalised as intangible assets, amounted to ¥8,538 million.」
The company continued its research and development investment and disclosed investment of ¥8,538 million for the current third-quarter consolidated cumulative period. It stated that there were no material changes in the status of its research and development activities. - FY2022-Q2RestatedAnnual report
「Research and development investment during the current second-quarter consolidated cumulative period, including development costs capitalised as intangible assets, amounted to ¥5,784 million. There were no material changes in the status of the Group's research and development activities during the current second-quarter consolidated cumulative period.」
The company continued its research and development investment and disclosed investment of ¥5,784 million for the current second-quarter consolidated cumulative period. It stated that there were no material changes in the status of its research and development activities. - FY2021-Q3RestatedAnnual report
「Research and development investment during the current third-quarter consolidated cumulative period, including development costs capitalised as intangible assets, amounted to ¥8,387 million. There were no material changes in the status of the Group's research and development activities during the current third-quarter consolidated cumulative period.」
The company continued its research and development investment and disclosed cumulative investment of ¥8,387 million. It stated that there were no material changes in the status of its research and development activities. - FY2021-Q2RestatedAnnual report
「Research and development investment during the current second-quarter consolidated cumulative period, including development costs capitalised as intangible assets, amounted to ¥5,592 million. There were no material changes in the status of the Group's research and development activities during the current second-quarter consolidated cumulative period.」
The company continued its research and development investment and disclosed investment of ¥5,592 million for the current second-quarter consolidated cumulative period. It stated that there were no material changes in the status of its research and development activities. - FY2020-Q3RestatedAnnual report
「Research and development investment during the current third-quarter consolidated cumulative period, including development costs capitalised as intangible assets, amounted to ¥9,728 million. There were no material changes in the status of the Group's research and development activities during the current third-quarter consolidated cumulative period.」
The company continued its research and development investment and disclosed investment of ¥9,728 million for the current third-quarter cumulative period. It stated that there were no material changes in the status of its research and development activities. - FY2020-Q2RestatedAnnual report
「Research and development investment during the current second-quarter consolidated cumulative period, including development costs capitalised as intangible assets, amounted to ¥6,413 million. There were no material changes in the status of the Group's research and development activities during the current second-quarter consolidated cumulative period.」
The company continued its research and development investment and disclosed investment of ¥6,413 million for the current second-quarter consolidated cumulative period. It stated that there were no material changes in the status of its research and development activities. - FY2020-Q1RestatedAnnual report
「Research and development investment during the current first-quarter consolidated cumulative period, including development costs capitalised as intangible assets, amounted to ¥3,205 million. There were no material changes in the status of the Group's research and development activities during the current first-quarter consolidated cumulative period.」
The company continued its research and development investment and disclosed investment of ¥3,205 million for the current first-quarter cumulative period. It stated that there were no material changes in the status of its research and development activities. - FY2019-Q3RestatedAnnual report
「Research and development investment during the current third-quarter consolidated cumulative period, including development costs capitalised as intangible assets, amounted to ¥8,508 million. There were no material changes in the status of the Group's research and development activities during the current third-quarter consolidated cumulative period.」
Research and development investment of ¥8,508 million on a cumulative basis was disclosed, and the company stated that there were no material changes in the status of its research and development activities. - FY2019-Q2RestatedAnnual report
「Research and development investment during the current second-quarter consolidated cumulative period, including development costs capitalised as intangible assets, amounted to ¥5,370 million. There were no material changes in the status of the Group's research and development activities during the current second-quarter consolidated cumulative period.」
The company continued its research and development investment and disclosed investment of ¥5,370 million for the current second-quarter consolidated cumulative period. It stated that there were no material changes in the status of its activities. - FY2019-Q1RestatedAnnual report
「Research and development investment during the current first-quarter consolidated cumulative period, including development costs capitalised as intangible assets, amounted to ¥2,569 million. There were no material changes in the status of the Group's research and development activities during the current first-quarter consolidated cumulative period.」
The company continued its research and development investment and disclosed investment of ¥2,569 million for the current first-quarter cumulative period. It stated that there were no material changes in the status of its research and development activities. - FY2018AdvancedAnnual report
「The Measurement business is pursuing collaborative development to generate synergies by complementing the technologies held by the Company, Anritsu Company (United States), Azimuth Systems, Inc. (United States), Anritsu Ltd. (United Kingdom), Anritsu A/S (Denmark) and other entities. During the consolidated fiscal year, the Company established Anritsu Philippines, Inc. as a development centre in the Philippines.」
In addition to its complementary development structure across Japan, the United States and Europe, the company established a development centre in the Philippines. Research and development investment was ¥10,556 million, or 12.3% of revenue. - FY2018-Q3RestatedAnnual report
「Research and development investment during the current third-quarter consolidated cumulative period, including development costs capitalised as intangible assets, amounted to ¥7,946 million. There were no material changes in the status of the Group's research and development activities during the current third-quarter consolidated cumulative period.」
The company continued its research and development investment and disclosed investment of ¥7,946 million for the current third-quarter consolidated cumulative period. It stated that there were no material changes in its research and development activities. - FY2018-Q2RestatedAnnual report
「Research and development investment during the current second-quarter consolidated cumulative period, including development costs capitalised as intangible assets, amounted to ¥5,343 million. There were no material changes in the status of the Group's research and development activities during the current second-quarter consolidated cumulative period.」
The company continued its research and development investment and disclosed investment of ¥5,343 million for the current second-quarter consolidated cumulative period. It stated that there were no material changes in the status of its activities. - FY2018-Q1RestatedAnnual report
「Research and development investment during the current first-quarter consolidated cumulative period, including development costs capitalised as intangible assets, amounted to ¥2,661 million. There were no material changes in the status of the Group's research and development activities during the current first-quarter consolidated cumulative period.」
The company continued its research and development investment and disclosed investment of ¥2,661 million for the current first-quarter cumulative period. It stated that there were no material changes in the status of its research and development activities. - FY2017AdvancedAnnual report
「Research and development investment for the consolidated fiscal year, including development costs recognized as intangible assets, comprised ¥8,324 million for the measurement business, ¥2,076 million for the PQA business, ¥609 million for other businesses and ¥202 million for basic research and development, for a total of ¥11,212 million, equivalent to 12.8% of revenue.」
Research and development investment for the full year is ¥11,212 million, or 12.8% of revenue, with specific new product development results described for both the Measurement and PQA businesses. - FY2017-Q3RestatedAnnual report
「In the measurement business, our company, Anritsu Company (US), Azimuth Systems, Inc. (US), Anritsu Ltd. (UK), Anritsu A/S (Denmark), Anritsu Solutions S.r.l. (Italy), Anritsu Solutions SK, s.r.o. (Slovakia) and other entities are collaborating on development to generate synergies by complementing one another’s technologies. Research and development investment during the nine months ended June 30, including development costs recognized as intangible assets, was ¥8,356 million. There were no material changes in the status of the Group’s research and development activities during the nine months ended June 30.」
The company described a complementary research and development structure spanning development centers in Japan, the United States and Europe, including Azimuth Systems, Inc. Research and development investment was ¥8,356 million, and it stated that there were no material changes in the status of activities. - FY2017-Q2RestatedAnnual report
「To contribute to the realization of a safe, secure and prosperous global society, we conduct global research and development of “original and high-level” products and services at our development centers in Japan, the United States and Europe. In the measurement business, our company, Anritsu Company (US), Anritsu Ltd. (UK), Anritsu A/S (Denmark), Anritsu Solutions S.r.l. (Italy) and Anritsu Solutions SK, s.r.o. (Slovakia) are collaborating on development to generate synergies by complementing one another’s technologies. Research and development investment during the six months ended June 30, including development costs recognized as intangible assets, was ¥5,519 million. There were no material changes in the status of the Group’s research and development activities during the six months ended June 30.」
The company continues its research and development structure utilizing development centers in Japan, the United States and Europe, and reported research and development investment of ¥5,519 million for the six months ended June 30. It stated that there were no material changes in the status of its activities. - FY2017-Q1RestatedAnnual report
「To contribute to the realization of a safe, secure and prosperous global society, we conduct global research and development of “original and high-level” products and services at our development centers in Japan, the United States and Europe. In the measurement business, our company, Anritsu Company (US), Anritsu Ltd. (UK), Anritsu A/S (Denmark), Anritsu Solutions S.r.l. (Italy) and Anritsu Solutions SK, s.r.o. (Slovakia) are collaborating on development to generate synergies by complementing one another’s technologies.」
The company reconfirmed its policy of conducting research and development at development centers in Japan, the United States and Europe, with the measurement business complementing the technologies of each center. Research and development investment was stated as ¥2,838 million. - FY2016First statedAnnual report
「The Group made strategic investments centered on new product development, enhanced the competitiveness of the solutions it provides and worked to establish the foundation for business expansion.」
New product development was positioned as the core of strategic investment. Research and development investment for the consolidated fiscal year was ¥13,089 million, equivalent to 13.7% of revenue.